DUCHEMBIO
Dyukem Bio Medical imaging scan (positron emission tomography, one person: PET) prescription drugs is a radiopharmaceutical used in a company to manufacture the meantime, nuclear medicine (Nuclear Medicine) income sales and co-operation of the relevant medical equipment, as well as radiopharmaceutical manufacturing By expanding the scope of supply and supply, we are now establishing a foundation as a comprehensive medical service company and will contribute to medical development.
DUCHEMBIO
Industry:
Health Care Pharmaceutical
Founded:
2002-01-01
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.duchembio.com
Status:
Active
Contact:
02-332-4868
Technology used in webpage:
SPF Nginx Google Apps For Business DigiCert SSL RapidSSL Korea Telecom Cafe24 DNS LINE WORKS
Current Employees Featured
Official Site Inspections
http://www.duchembio.com
- Host name: 183.111.199.231
- IP address: 183.111.199.231
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "DuChemBio"
DuChemBio | Company Profile - 듀켐바이오
Greetings from DuChemBio CEO. The passion to challenge a new market where everything is a beginning! With our experience in Korea, we will pursue the passion in Southeast Asia. Go to Greetings from the CEO. Address 6,7F, 81, …See details»
듀켐바이오
제조기술 기반의 차세대 암 진단 및 치료 방사성의약품 개발 기업 (주)듀켐바이오See details»
DuChemBio - Crunchbase Company Profile & Funding
Where is DuChemBio 's headquarters? DuChemBio is located in Seoul, Seoul-t'ukpyolsi, South Korea. Who invested in DuChemBio? DuChemBio is funded by Company K Partners. When …See details»
Korea's No. 1 Radiopharmaceutical Company Innovation-driven ...
Duchembio, Co., Ltd. l Provider of next-generation diagnostic and therapeutic radiopharmaceuticals New Duchembio Overview 7 Company Name Duchembio Co., Ltd. CEO …See details»
Duchembio Co., Ltd. Overview | SignalHire Company Profile
Organization Website: duchembio.com : Phone Number: 8223324868: Duchembio Co., Ltd. industries PharmaSee details»
DuChemBio Company Profile 2024: Stock Performance …
What is DuChemBio’s annual earnings per share (EPS)? DuChemBio’s EPS for 12 months was $0.11. Data Transparency. Meet our data hygiene team. Discover how our experts ensure you’re getting the most accurate financial data in the …See details»
DuChemBIO Co.,Ltd. Company Description - Stock Analysis
3 days ago DuChemBIO Co.,Ltd. engages in the development, production, and sale of radiopharmaceutical products for cancer diagnosis and treatment in South Korea. Its products …See details»
Duchem Bio - Company Profile - Tracxn
Nov 27, 2024 Duchem Bio - Radiopharmaceuticals for diagnostics and therapeutic use. Public Company. Raised funding from 3 investors. Duchem Bio has 84 competitors.See details»
DuChemBio Co., Ltd. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for DuChemBio Co., Ltd. of Seoul, Seoul. Get the latest business insights from Dun & Bradstreet.See details»
DuChemBio - Overview, News & Similar companies | ZoomInfo.com
Who is DuChemBio. Established in 2002, DuChemBio is the largest radiopharmaceutical firm and the undisputed leader in the field of oncology and neurology PET imaging tracers in South …See details»
Duchembio Co. Ltd. Company Profile - South Korea - EMIS
Jul 5, 2024 Financial values in the chart are available after Duchembio Co. Ltd. report is purchased. Looking for more than just a company report? EMIS company profiles are part of a …See details»
DuChemBio | History - 듀켐바이오
DuChemBio Co.,LTD.-DuChemBio Research Institute small-scale merger: 11. Launched FACBC (18F-Fluciclovine), 1st PET diagnostic agent for recurrent prostate cancer: 09. National …See details»
DuChemBio - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 10, 2024 Organization. DuChemBio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Monthly Visits 1,128. Monthly …See details»
DuChemBio - Products, Competitors, Financials, Employees, …
Approval of Alzheimer’s Drug ‘Donanemab’ Brings Positive Outlook for Duchembio. Jul 4, 2024. Increased Demand Expected for Duchembio, Specialist in Radiopharmaceuticals Posted in …See details»
DuChemBio - Contacts, Employees, Board Members, Advisors
Organization. DuChemBio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. DuChemBio has …See details»
Duchembio files for IPO to grow radiopharma business
Nov 11, 2024 Radiopharmaceutical biotech and contract development and organization firm Duchembio Co. Ltd. filed a securities report to South Korea’s Financial Services Commission …See details»
DuChemBio | Greetings from CEO - 듀켐바이오
DuChemBio. “Ceaselessly Securing Manufacturing Technologies” The Radiopharmaceutical industry is clearly distinguished from other pharmaceutical businesses, particularly in terms of …See details»
[2022] DuChemBio Organizational Resilience Analysis - EMBA Pro
Organization Resilience Introduction . The world is going through two major crises at the moment – Covid 19 health crisis and the on-going US China trade war that can determine the future of …See details»